Related Experiment Video
Updated: Feb 5, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Dilating Vascular Diseases: Pathophysiology and Clinical Aspects
1Private Yenisehir Hospital, Department of Cardiology, Mersin, Turkey.
Vessel dilation diseases, including varicose veins and aneurysms, are distinct from atherosclerosis but share similarities. These conditions suggest a systemic vessel wall disease requiring comprehensive patient evaluation.
Area of Science:
- Vascular Medicine
- Cardiovascular Pathology
Background:
- Atherosclerotic disease significantly impacts global mortality and morbidity.
- Vessel dilation, encompassing venous (varicocele, varicose veins, hemorrhoids) and arterial (aneurysms) conditions, represents a distinct vascular pathology.
- These dilating vascular diseases are often misclassified as variants of atherosclerosis despite distinct characteristics.
Purpose of the Study:
- To differentiate dilating vascular diseases from atherosclerosis.
- To highlight the pathophysiological and histological similarities between arterial and venous dilating diseases.
- To propose a systemic view of vessel wall disease.
Main Methods:
- Review of existing literature on atherosclerotic and dilating vascular diseases.
- Comparative analysis of pathogenesis, histology, and clinical presentation.
- Synthesis of evidence supporting a systemic vessel wall disease model.
Main Results:
- Dilating vascular diseases share pathophysiological and histological similarities with each other.
- Clinical coexistence of these arterial and venous diseases is frequently observed.
- Despite similarities, dilating vascular diseases are distinct from atherosclerosis.
Conclusions:
- Dilating vascular diseases should be considered a systemic vessel wall disease, not merely local afflictions.
- Patients with any dilating vascular disease require systematic evaluation for other related conditions.
- Recognizing these conditions as systemic enhances patient management and prognosis.
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Coronary Artery Disease II: Pathophysiology
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

